Trial · NCT00811057
Tocolysis for Preterm Labor
NCT00811057, Not applicable, Completed, University of Mississippi Medical Center; results first posted 2013-04-04
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Tocolysis for Preterm Labor. Trials, record NCT00811057. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT00811057
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Tocolysis for Preterm Labor
- NCT number
- NCT00811057
- Status
- Completed
- Phases
- Not applicable
- Enrollment
- 301 participants, actual
- Lead sponsor
- University of Mississippi Medical Center
- Conditions
- Preterm Labor
- Interventions
- 1 Magnesium Sulfate, Nifedipine, Indomethacin
- First posted
- 2008-12-18
- Last updated
- 2013-04-04
- Results first posted
- 2013-04-04
Source ClinicalTrials.gov
Registered outcomes2
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | The Primary Outcome Measure of This Research is to Compare the Efficacy of the Three Clinically Used Tocolytic Agents in a Prospective Study That Will Allow Direct Comparison of Outcomes in Women With Confirmed Preterm Labor. | 3-5 days after delivery | Gestational age at delivery in weeks. |
| Secondary | The Secondary Outcome Measure of This Research is the Days Gained After Treatment to Delivery | after delivery of the infant | Days gained after treatment to delivery |
Source ClinicalTrials.gov
Outcomes2
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | The Primary Outcome Measure of This Research is to Compare the Efficacy of the Three Clinically Used Tocolytic Agents in a Prospective Study That Will Allow Direct Comparison of Outcomes in Women With Confirmed Preterm Labor. | 3-5 days after delivery | weeks | MEAN | |
| SECONDARY | The Secondary Outcome Measure of This Research is the Days Gained After Treatment to Delivery | after delivery of the infant | days | MEAN |
Source ClinicalTrials.gov
Results by group6
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
The Primary Outcome Measure of This Research is to Compare the Efficacy of the Three Clinically Used Tocolytic Agents in a Prospective Study That Will Allow Direct Comparison of Outcomes in Women With Confirmed Preterm Labor. | 1 Magnesium Sulfate | 31.2 | Standard Deviation 3.9 | weeks | |
The Primary Outcome Measure of This Research is to Compare the Efficacy of the Three Clinically Used Tocolytic Agents in a Prospective Study That Will Allow Direct Comparison of Outcomes in Women With Confirmed Preterm Labor. | 2 Nifedipine | 31.8 | Standard Deviation 4.5 | weeks | |
The Primary Outcome Measure of This Research is to Compare the Efficacy of the Three Clinically Used Tocolytic Agents in a Prospective Study That Will Allow Direct Comparison of Outcomes in Women With Confirmed Preterm Labor. | 3 Indomethacin | 31.8 | Standard Deviation 4.2 | weeks | |
| The Secondary Outcome Measure of This Research is the Days Gained After Treatment to Delivery | 1 Magnesium Sulfate | 22.5 | Standard Deviation 43.8 | days | |
| The Secondary Outcome Measure of This Research is the Days Gained After Treatment to Delivery | 2 Nifedipine | 21.7 | Standard Deviation 21.7 | days | |
| The Secondary Outcome Measure of This Research is the Days Gained After Treatment to Delivery | 3 Indomethacin | 22.7 | Standard Deviation 21.1 | days |
Source ClinicalTrials.gov
Participant flow9
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted |
|---|---|---|---|---|
| Overall Study | STARTED | 1 Magnesium Sulfate | 90 | |
| Overall Study | STARTED | 2 Nifedipine | 114 | |
| Overall Study | STARTED | 3 Indomethacin | 97 | |
| Overall Study | COMPLETED | 1 Magnesium Sulfate | 85 | |
| Overall Study | COMPLETED | 2 Nifedipine | 104 | |
| Overall Study | COMPLETED | 3 Indomethacin | 87 | |
| Overall Study | NOT COMPLETED | 1 Magnesium Sulfate | 5 | |
| Overall Study | NOT COMPLETED | 2 Nifedipine | 10 | |
| Overall Study | NOT COMPLETED | 3 Indomethacin | 10 |
Source ClinicalTrials.gov
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals9
The totals the trial posted for each group.
| Total | Group | Affected | At risk |
|---|---|---|---|
| Total, all-cause mortality | 1 Magnesium Sulfate | ||
| Total, all-cause mortality | 2 Nifedipine | ||
| Total, all-cause mortality | 3 Indomethacin | ||
| Total, other adverse events | 1 Magnesium Sulfate | 0 | 90 |
| Total, other adverse events | 2 Nifedipine | 0 | 114 |
| Total, other adverse events | 3 Indomethacin | 0 | 97 |
| Total, serious adverse events | 1 Magnesium Sulfate | 0 | 90 |
| Total, serious adverse events | 2 Nifedipine | 0 | 114 |
| Total, serious adverse events | 3 Indomethacin | 0 | 97 |
Source ClinicalTrials.gov
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 35947046 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT00811057
GET https://conductscience.org/api/trials/v1/NCT00811057/registered